Shanghai MicroPort Endovascular MedTech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Qing Zhu
Chief executive officer
CN¥940.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.3yrs |
| CEO ownership | n/a |
| Management average tenure | 4.6yrs |
| Board average tenure | 1.9yrs |
Recent management updates
Recent updates
A Look At The Fair Value Of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016)
Mar 24
Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Shares Lagging The Market But So Is The Business
Jan 03Investors Met With Slowing Returns on Capital At Shanghai MicroPort Endovascular MedTech (SHSE:688016)
Dec 16Calculating The Fair Value Of Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHSE:688016)
Nov 27Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Attractive Earnings Are Not All Good News For Shareholders
Nov 06There's No Escaping Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Muted Earnings Despite A 31% Share Price Rise
Oct 01Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 16% And Analysts Are Revising Their Forecasts
Aug 29Shanghai MicroPort Endovascular MedTech (SHSE:688016) Will Want To Turn Around Its Return Trends
Aug 15Investors Don't See Light At End Of Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Tunnel
Jun 29These 4 Measures Indicate That Shanghai MicroPort Endovascular MedTech (SHSE:688016) Is Using Debt Safely
Apr 29Shanghai MicroPort Endovascular MedTech's (SHSE:688016) Earnings Are Weaker Than They Seem
Apr 09Shanghai MicroPort Endovascular MedTech Co., Ltd.'s (SHSE:688016) Business Is Trailing The Market But Its Shares Aren't
Mar 25CEO
Qing Zhu (44 yo)
Mr. Qing Zhu, Ph D., is GM & Director of Shanghai MicroPort Endovascular MedTech Co., Ltd. He was Deputy General Manager of Shanghai MicroPort Endovascular MedTech Co., Ltd.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥940.00k | no data | |
| Accounting Supervisor & CFO | 4yrs | CN¥1.13m | no data | |
| Deputy GM & Secretary of the Board of Directors | 3.5yrs | CN¥1.58m | no data | |
| Deputy GM & Core Technical Personnel | 6.6yrs | CN¥1.60m | no data | |
| Deputy GM & Core Technical Personnel | 5.2yrs | CN¥1.58m | no data | |
| Senior Director | no data | CN¥1.54m | no data | |
| Core Technical Staff | no data | CN¥488.00k | no data | |
| Core Technical Staff | no data | CN¥687.10k | no data |
Experienced Management: 688016's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 7.3yrs | CN¥940.00k | no data | |
| Chairman | 1.9yrs | no data | no data | |
| Employee Representative Supervisor | 7.3yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥100.00k | no data | |
| Director | 1.8yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Chairman of the Supervisory Board | 1.9yrs | no data | no data | |
| Supervisor | 1.9yrs | no data | no data |
Experienced Board: 688016's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 16:22 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai MicroPort Endovascular MedTech Co., Ltd. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yuan Gao | China International Capital Corporation Limited |
| Bo Yu | China International Capital Corporation Limited |